Annual CFO
-$21.13 M
+$27.69 M+56.72%
31 December 2023
Summary:
Mereo BioPharma annual cash flow from operations is currently -$21.13 million, with the most recent change of +$27.69 million (+56.72%) on 31 December 2023. During the last 3 years, it has risen by +$17.49 million (+45.29%). MREO annual CFO is now -198.87% below its all-time high of -$7.07 million, reached on 31 December 2021.MREO Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CFO
-$7.52 M
+$385.00 K+4.87%
30 September 2024
Summary:
Mereo BioPharma quarterly cash flow from operations is currently -$7.52 million, with the most recent change of +$385.00 thousand (+4.87%) on 30 September 2024. Over the past year, it has dropped by -$10.18 million (-382.78%). MREO quarterly CFO is now -382.78% below its all-time high of $2.66 million, reached on 30 September 2023.MREO Quarterly CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CFO
-$30.20 M
-$10.18 M-50.83%
30 September 2024
Summary:
Mereo BioPharma TTM cash flow from operations is currently -$30.20 million, with the most recent change of -$10.18 million (-50.83%) on 30 September 2024. Over the past year, it has dropped by -$15.86 million (-110.58%). MREO TTM CFO is now -226.59% below its all-time high of -$9.25 million, reached on 21 March 2023.MREO TTM CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
MREO Cash From Operations Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +56.7% | -382.8% | -110.6% |
| 3 y3 years | +45.3% | - | - |
| 5 y5 years | +28.0% | - | - |
MREO Cash From Operations High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -198.9% | +56.7% | -382.8% | +18.7% | -226.6% | at low |
| 5 y | 5 years | -198.9% | +64.9% | -382.8% | +18.7% | -226.6% | at low |
| alltime | all time | -198.9% | +64.9% | -382.8% | +18.7% | -226.6% | at low |
Mereo BioPharma Cash From Operations History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$7.52 M(-4.9%) | -$30.20 M(+50.8%) |
| June 2024 | - | -$7.90 M(-1.1%) | -$20.02 M(+0.8%) |
| Mar 2024 | - | -$7.99 M(+17.7%) | -$19.88 M(-5.9%) |
| Dec 2023 | -$21.13 M(-56.7%) | -$6.79 M(-355.3%) | -$21.13 M(+47.3%) |
| Sept 2023 | - | $2.66 M(-134.3%) | -$14.34 M(-15.6%) |
| June 2023 | - | -$7.75 M(-16.2%) | -$17.00 M(+83.8%) |
| Mar 2023 | - | -$9.25 M | -$9.25 M |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2022 | -$48.82 M(+590.5%) | - | - |
| Dec 2021 | -$7.07 M(-81.7%) | - | - |
| Dec 2020 | -$38.62 M(-35.9%) | - | - |
| Dec 2019 | -$60.22 M(+105.1%) | - | - |
| Dec 2018 | -$29.36 M(-32.4%) | - | - |
| Dec 2017 | -$43.45 M(+18.7%) | - | - |
| Dec 2016 | -$36.60 M | - | - |
FAQ
- What is Mereo BioPharma annual cash flow from operations?
- What is the all time high annual CFO for Mereo BioPharma?
- What is Mereo BioPharma annual CFO year-on-year change?
- What is Mereo BioPharma quarterly cash flow from operations?
- What is the all time high quarterly CFO for Mereo BioPharma?
- What is Mereo BioPharma quarterly CFO year-on-year change?
- What is Mereo BioPharma TTM cash flow from operations?
- What is the all time high TTM CFO for Mereo BioPharma?
- What is Mereo BioPharma TTM CFO year-on-year change?
What is Mereo BioPharma annual cash flow from operations?
The current annual CFO of MREO is -$21.13 M
What is the all time high annual CFO for Mereo BioPharma?
Mereo BioPharma all-time high annual cash flow from operations is -$7.07 M
What is Mereo BioPharma annual CFO year-on-year change?
Over the past year, MREO annual cash flow from operations has changed by +$27.69 M (+56.72%)
What is Mereo BioPharma quarterly cash flow from operations?
The current quarterly CFO of MREO is -$7.52 M
What is the all time high quarterly CFO for Mereo BioPharma?
Mereo BioPharma all-time high quarterly cash flow from operations is $2.66 M
What is Mereo BioPharma quarterly CFO year-on-year change?
Over the past year, MREO quarterly cash flow from operations has changed by -$10.18 M (-382.78%)
What is Mereo BioPharma TTM cash flow from operations?
The current TTM CFO of MREO is -$30.20 M
What is the all time high TTM CFO for Mereo BioPharma?
Mereo BioPharma all-time high TTM cash flow from operations is -$9.25 M
What is Mereo BioPharma TTM CFO year-on-year change?
Over the past year, MREO TTM cash flow from operations has changed by -$15.86 M (-110.58%)